These mediators span across Th1/M1, Th17—anti-parasitic and infection clearance-related immune responses [44]—suggesting that in addition to mediating tumour cell killing, IgE cross-linking possibly enhances monocyte-mediated anti-tumour immunological cascades that employ different arms of immunity. This evidence concerns the gene IGHE and neoplasm.